Synthesis and antitubercular activity of heteroaromatic isonicotinoyl and 7-chloro-4-quinolinyl hydrazone derivatives

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 1347-1355

  Ferreira, Marcelle De L ^a,b   Gonçalves, Raoni S B ^a,b   Cardoso, Laura N De F ^a   Kaiser, Carlos R ^b   Candéa, André L P ^a   Henriques, Maria Das Graças M De O ^a   Lourenço, Maria C S ^c   Bezerra, Flávio A F M ^c   De Souza, Marcus V N ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Funda??o Oswaldo Cruz   (Brazil)

Author keywords

Drugs; Isoniazid; Quinoline; Tuberculosis

Indexed keywords

(7 CHLORO 4 QUINOLYL)HYDRAZINE; 1 (7 CHLOROQUINOLIN 4 YL) 2 [(2 PYRIDYL)METHYLENE] HYDRAZINE; 1 (7 CHLOROQUINOLIN 4 YL) 2 [(5 NITRO FURAN 2 YL)METHYLENE] HYDRAZINE; 1 (7 CHLOROQUINOLIN 4 YL) 2 [(5 NITRO THIOPHEN 2 YL)METHYLENE] HYDRAZINE; ETHAMBUTOL; HYDRAZONE DERIVATIVE; ISONIAZID; N' [ (1H IMIDAZOL 2 YL)METHYLIDENE] ISONICOTINOHYDRAZIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTITUBERCULAR ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; MICROBIOLOGICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS;

MYCOBACTERIUM TUBERCULOSIS H37RV;

ANTITUBERCULAR AGENTS; HYDRAZONES; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 77955901416     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.124     Document Type: Article

References (24)

1. http://www.who.int/topics/tuberculosis/en/ (date of access: 01-30-2010)
2. De Souza, M.V.N. (2006) Promising drugs against tuberculosis. Rec. Pat. Anti-Infect. Drug Discov. 1, 33-45.
3. De Souza, M.V.N. (2009) Promising candidates in clinical trials against multidrug-resistant tuberculosis (MDR-TB) based on natural products. Fitoterapia 80, 453-460.
4. Lourenco, M.C., Ferreira, M.L., De Souza, M.V.N., Peralta, M.A., Vasconcelos, T.A., and Henrique, M.G.M.O. (2008) Synthesis and anti-mycobacterial activity of of (E)-N-(monosubstituted-benzylidene) isonicotinohydrazide derivatives. Eur. J. Med. Chem. 43, 1344-1347.
5. De Souza, M.V.N., Neves Junior, I., Miranda, G.B.P., Lourenco, M.C.S., Vasconcelos, T.A., Pais, K.C., Wardell, J.L., Wardell, S.M.S.V., and Alcântara Junior, J.P. (2006) Synthesis and in vitro anti-tubercular activity of a series of N'(disubstitutedbenzoyl)isoniazid derivatives. Lett. Drug Des. Discov. 3, 424-428.
6. De Souza, M.V.N., Vasconcelos, T.R.A., Mello, S.C.P., Wardell, S.M.S.V., Peralta, M.A., Ferreira, B., Henrique, M.G.M.O., Neves Junior, I., and Lourenco, M.C.S. (2005) Synthesis and anti-mycobacterial activity of N′[(E)- (disubstituted-phenyl)methylidene]isonicotino-hydrazine derivatives. Lett. Drug Des. Discov. 2, 563-566.
7. De Souza, M.V.N., Ferreira, M.L., Pinheiro, A.C., Saraiva, M.F., Almeida, M.V., and Valle, M.S. (2008) Synthesis and biological aspects of mycolic acids: an important target against Mycobacterium tuberculosis. TheScientificWorldJOURNAL 8, 720-751.
8. Heym, B., Saint-Joanis, B., and Cole, S.T. (1999) The molecular basis of isoniazid resistance in Mycobacterium tuberculosis. Tuber. Lung Dis. 79(4), 267-271.
9. Zelenin, K.N., Khorseeva, L.A., and Alekseev, V.V. (1992) Physiologically active complexes of hydrazones. Pharm. Chem. J. 26(5), 395-405.
10. Gemma, S., Savini, L., Altarelli, M., Tripaldi, P., Chiasserini, L., Coccone, S.S., Kumar, V., Camodeca, C., Campiani, G., Novellino, E., Clarizio, S., Delogu, G., and Butini, S. (2009) Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies. Bioorg. Med. Chem. 17, 6063-6072.
11. Richardson, D.R., Sharpe, P.C., Lovejoy, D.B., Senaratne, D., Kalinowski, D.S., Islam, M., and Bernhardt, P.V. (2006) Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity. J. Med. Chem. 49, 6510-6521.
12. Sarel, S., Fizames, C., Lavelle, F., and Avramovici-Grisaru, S. (1999) Domain-structured N1,N2-derivatized hydrazines as inhibitors of ribonucleoside diphosphate reductase: redox-cycling considerations. J. Med. Chem. 42(2), 242-248.
13. Candéa, A.L.P., Ferreira, M.L., Pais, K.C., Cardoso, L.N.F., Kaiser, C.R., Henriques, M.G.M.O., Lourenço, M.C.S., Bezerra, F.A.F.M., and De Souza, M.V.N. (2009) Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives. Bioorg. Med. Chem. Lett. 19, 6272-6274.
14. Chohan, Z.H., Arif, M., Shafiq, Z., Yaqub, M., and Supuran, C.T. (2006) In vitro antibacterial, antifungal and cytotoxic activity of some isonicotinoylhydrazide Schiff's bases and their cobalt (II), copper (II), nickel (II) and zinc (II) complexes. J. Enzyme Inhib. Med. Chem. 21(1), 95-103
15. Sharma, V.K., Srivastava, S., and Srivastava, A. (2006) Synthesis and spectroscopic studies of novel mononuclear and binuclear ruthenium (III) complexes with bidentate and tridentate acyclic hydrazones. J. Coord. Chem. 59(12), 1321-1334.
16. De Souza, M.V.N., Wardell, J.L., Low, J.N., and Glidewell, C. (2006) Pyrrole-2-carbaldehyde isonicotinoylhydrazone monohydrate redetermined at 120K. Acta Crystallogr. C C62, 47-49.
17. Minoo, D., Peyman, S., and Mostafa, B. (2006) A facile procedure for the one-pot synthesis of unsymmetrical 2,5-disubstituted 1,3,4-oxadiazoles. Tetrahedron Lett. 47, 6983-6986.
18. Fattorusso, C., Campiani, G., Kukreja, G., Persico, M., Butini, S., Romano, M.P., Altarelli, M., Ros, S., Brindisi, M., Savini, L., Novellino, E., Nacci, V., Fattorusso, E., Parapini, S., Basilico, N., Taramelli, D., Yardley, V., Croft, S., Borriello, M., and Gemma, S. (2008) Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents. J. Med. Chem. 51(5), 1333-1343.
19. Canetti, J., Rist, E., and Grosset, R. (1963) [Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation.] Rev. Tuberc. Pneumol. (Paris) 27, 217-272. [French]
20. Franzblau, S.G., Witzig, R.S., McLaughlin, J.C., Torres, P., Madico, G., Hernandez, A., Degnan, M.T., Cook, M.B., Quenzer, V.K., Ferguson, R.M., and Gilman, R.H.J. (1998) Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. Clin. Microbiol. 36, 362-366.
21. Vanitha, J.D. and Paramasivan, C.N. (2004) Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates. Diagn. Microbiol. Infect. Dis. 49, 179.
22. Reis, R.S., Neves, I., Jr., Lourenço, S.L.S.,; Fonseca, L.S., and Lourenço, M.C.S.J. (2004) Comparison of flow cytometric and Alamar Blue tests with the proportional method for testing susceptibility of Mycobacterium tuberculosis to rifampin and isoniazid. Clin. Microbiol. 42(5), 2247-2248.
23. Souza, M.C., Siani, A.C., Ramos, M.F.S., Jr., Limas, O.M., and Henrique, M.G.M.O. (2003) Evaluation of antiinflammatory activity of essential oils from two asteraceae species. Pharmazie 58(8), 582-586.
24. Carvalho, M.V., Monteiro, C.P., Siani, A.C., Valente, L.M.M., and Henriques, M.G.M.O. (2006) Investigations on the anti-inflammatory and anti-allergic activities of the leaves of Uncaria guianensis (Aublet) J. F. Gmelin. Inflammopharmacology 14(1-2), 48-56.